- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02681718
Controlling Hyperglycemia Among Minority Population (CHAMP)
January 24, 2018 updated by: Sinai Health System
Controlling Hyperglycemia Among Minority Population (CHAMP): A Randomized Controlled Trial of Two Diabetes Interventions for Underserved Communities
The purpose of this study is to compare the efficacy of three approaches in diabetes management: (1) community health worker (CHW) education; (2) text messaging; and (3) usual hospital-based care.
The goal is to determine the most cost-effective method of diabetes management among an economically-disadvantaged, minority population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The CHAMP study will test the efficacy of two interventions designed to decrease uncontrolled hyperglycemia (defined as Hemoglobin-A1C (A1C) at or above 9%) among adults with diabetes.
Patients from a safety-net hospital will be randomized into three groups: 1) a control group, 2) an intervention providing diabetes self-care text messages, or 3) an intervention using community health workers to provide diabetes education and linkage to care.
Secondary objectives include increasing diabetes knowledge, improving diabetes self-management, and increasing use of primary care (i.e., make one visit to the physician in 6 months) among the intervention participants.
A cost-effectiveness analysis will determine the most appropriate way to reduce the burden of uncontrolled diabetes.
Study Type
Interventional
Enrollment (Actual)
272
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60608
- Mount Sinai Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
*Hyperglycemia with A1C ≥9%
Exclusion Criteria:
- Lives greater than 20 miles driving distance from Mount Sinai Hospital
- Pregnant women with gestational diabetes
- Advanced end-organ complications due to diabetes that include: end-stage renal disease, stroke with paresis, Congestive Heart Failure (NYHA class III or IV), or other major end-organ complication of diabetes
- Receiving treatment for a major psychiatric disorder (i.e. schizophrenia)
- Unable to understand and give informed consent in either English or Spanish
- Currently or previously participated in a diabetes research study
- Family member currently enrolled in a diabetes research study
- Previously received diabetes care related cell phone text messages
- Unable to receive text messages 3-4 times per week
- Living in a homeless shelter or temporary housing
- Plans to travel outside of the United States for more than 3 months in next year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Community Health Worker education
During a six-month intervention period, the CHWs will conduct six home-based visitations and provide individualized diabetes education using an intensive diabetes lifestyle curriculum called Diabetes Learning Circle (DLC), developed and used by the Sinai Diabetes Education Program.
At each visit, lasting for approximately one hour, the participants will be motivated to set SMART behavioral goals for diabetes self-management.
At each visit after the initial visit, CHWs will follow-up with each participant to check their progress on their behavioral SMART goals.
In addition, the CHWs will conduct intermittent phone calls (at least one monthly) and home visits as needed.
|
Diabetes self-management education by community health workers
|
|
Experimental: Cell phone text messaging
The participants in the text messaging group will receive weekly text messages through CareMessage.
Each participant will receive 3-4 text messages per week for 6 months.
|
Diabetes self-management education through cell phone text messaging
|
|
No Intervention: Control
The participants in the control group will receive education as determined by the hospital's diabetes educator, dietitian, physician, or the participant's managed care provider.
No additional education will be provided by the research team.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in Hemoglobin A1C (CHW vs. Control)
Time Frame: 6 months
|
To assess whether there is a statistically significant difference in HbA1C level between CHW and control groups at 6 months follow-up.
|
6 months
|
|
Difference in Hemoglobin A1C (Text Message vs. Control)
Time Frame: 6 months
|
To assess whether there is a statistically significant difference in HbA1C level between text message and control groups at 6 months follow-up.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage change in diabetes knowledge test scores
Time Frame: 6 months
|
Michigan Diabetes and Research Center Knowledge test
|
6 months
|
|
Mean change in diabetes self-efficacy scores
Time Frame: 6 months
|
Perceived competence in diabetes scale
|
6 months
|
|
Mean change in diabetes distress scores
Time Frame: 6 months
|
Problem areas in diabetes (PAID-5) scale
|
6 months
|
|
Mean change in participants' beliefs about using insulin scores
Time Frame: 6 months
|
Insulin treatment appraisal (ITAS) scale
|
6 months
|
|
Mean changes in diabetes self-care activities
Time Frame: 6 months
|
Diabetes self-care activities include: diet, physical activity, self-monitoring of blood glucose, foot-care, and smoking
|
6 months
|
|
Percentage of participants who visited a physician due to a diabetes related follow-up
Time Frame: 6 months
|
Self- reported
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
September 1, 2017
Study Completion (Actual)
September 1, 2017
Study Registration Dates
First Submitted
February 3, 2016
First Submitted That Met QC Criteria
February 11, 2016
First Posted (Estimate)
February 12, 2016
Study Record Updates
Last Update Posted (Actual)
January 26, 2018
Last Update Submitted That Met QC Criteria
January 24, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSH15-46
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceCompletedType 2 Diabetes Mellitus | Pre DiabetesAustralia
Clinical Trials on Community health worker education
-
University of ArizonaNational Institute on Deafness and Other Communication Disorders (NIDCD)UnknownHearing LossUnited States
-
University of Southern CaliforniaCenters for Disease Control and Prevention; Association of American Medical...Completed
-
Unity Health TorontoNot yet recruitingSchizophrenia | Bipolar Disorder
-
Massachusetts General HospitalCompleted
-
Columbia UniversityNational Institutes of Health (NIH)Completed
-
Massachusetts General HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdherence, Patient | Zika Virus InfectionPuerto Rico
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Completed
-
University Hospitals Cleveland Medical CenterCompletedCardiovascular Diseases | Smoking | Hypertension | DiabetesIndia
-
University of MiamiNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Unity Health TorontoUniversity of Manitoba; Dalhousie University; University of Saskatchewan; Memorial...Not yet recruiting